It focuses on the implications of excess intracellular levels of GSH - as opposed to inadequate extracellular GSH, which is what we are treating by taking GSH - suggesting that this is more of a problem. I do not yet quite understand what the therapeutic implications are, as I am just trying to get my head around all of this. They suggest isothiocyanates.
This article is three years old. I am wondering if anyone knows of any more recent research into this side of things? Is there any data to support this hypothesis?
Does anyone know any more about this? Or have any thoughts to share?